Pre-Market Buzz: Cleveland BioLabs (CBLI), SunEdison (SEMI), IAC/InterActiveCorp (IACI), BlackBerry (BBRY)

Shares of Cleveland BioLabs, Inc. (CBLI) climbed over 106% Thursday on news of a securities purchase agreement with David Davidovich, a venture capital investor, for the sale of 6,459,948 unregistered common shares at a price of $3.87 per share for an aggregate of $25 million. The offering represents a 35% premium to the closing market price of $2.86 on June 23, 2015. The parties expect to close the transaction on or about July 6, 2015.

Shares of SunEdison Semiconductor Limited (SEMI) are down more than 4% this morning after the company announced the commencement of an underwritten public offering of more than 15.9 million ordinary shares by selling shareholders. Deutsche Bank (DB) and Goldman Sachs (GS) are acting as lead book-running managers for the offering.

Shares of IAC/InterActiveCorp (IACI) are higher by nearly 6% to $81.80 in pre-market trading on Thursday after the company announced its intent to pursue IPO of The Match Group, which includes the websites Match.com and OurTime.com, and the Princeton Review. IAC also announced that Joey Levin, formerly CEO of its Search & Applications business, has been named CEO of IAC and joined its Board of Directors. Greg Blatt will remain Chairman, and Sam Yagan CEO, of The Match Group.

BlackBerry (BBRY) — The smartphone maker today announced plans to buy back up to 12 million shares of common stock to offset the dilution from a new employee stock purchase plan.

“We intend to take advantage of our strong cash position to purchase our shares when the market price does not reflect what we view to be the underlying value and future prospects of our business, without adversely affecting our strategic initiatives,” commented BlackBerry Executive Chairman and CEO, John Chen.

The buyback program will run from Monday through June 28, 2016.

Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!

Be the first to comment

Leave a Reply

Your email address will not be published.


*

This site uses Akismet to reduce spam. Learn how your comment data is processed.